Biotechnology company specializing on development and delivery of psychedelics therapies Field trip Health Ltd (TSX: FTRP) (OTCQX: FTRPF) announced having received conditional approval to get listed on Nasdaq Stock Market LLC under the ticker symbol ‘FTRP’.
According to this conditional approval, Field Trip is expected to list its common outstanding shares on Nasdaq Global Select Market. A final approval for the listing is subject to regulatory requirements by Nasdaq.
Field Trip is looking forward to meet all required requirements so that it can issue a statement once a commencement trading date is confirmed by Nasdaq.
The company says its common stock will continue trading in Canada on the TSX Exchange under current ticket symbol ‘FTRP’ and on the United States OTC markets under its ticker ‘FTRPF’ until the company shares start trading on Nasdaq.
“The anticipated listing of our stock on the Nasdaq is a key milestone in our evolution as a publicly-traded company. We believe this anticipated listing will improve liquidity by enabling more investors to participate in our growth, and ultimately enhance long-term shareholder value. This is a critical time for us to increase our visibility in the marketplace, as we continue our work building a world-class and disruptive company at the forefront of the psychedelics industry,” said the company’s chief executive, Joseph del Moral.
